Successful management of steroid-resistant nephrotic syndrome using ibuprofen

Clinical Nephrology

Volumn 47, Issue 1, 1997, Pages 60-62

  Low, C Luan ^a   McGoldrick, M D ^b   Bailie, G R ^a  

^a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Focual segmental glomerulosclerosis; Ibuprofen; Proteinuria; Steroid resistant nephrotic syndrome

Indexed keywords

CYCLOPHOSPHAMIDE; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ADULT; ARTICLE; CASE REPORT; FOCAL GLOMERULOSCLEROSIS; HUMAN; MALE; NEPHROTIC SYNDROME; PERICARDITIS; PROTEINURIA; RELAPSE;

ADMINISTRATION, ORAL; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOPSY; CYCLOPHOSPHAMIDE; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; IBUPROFEN; IMMUNOSUPPRESSIVE AGENTS; MALE; NEPHROTIC SYNDROME; PREDNISONE;

EID: 0031024914     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Donker AJM, Brentjens JRH, van der Hem GK, Arisz L 1978 Treatment of the nephrotic syndrome with indomethacin. Nephron 22: 374-381
2. Cardin EH, Williams RL, Fennell RS, Richard GA 1978 Indomethacin in the treatment of idiopathic minimal lesion nephrotic syndrome. J Pediatr 93: 138-140
3. Kleinknecht C, Broyer M, Grubler MC, Palcoux JB 1980 Irreversible renal failure after indomethacin in steroid-resistant nephrosis. (Letter-to-the-editor) N Engl J Med 302: 69
4. Maki DD, Ma JZ, Louis TA, Kasiske BL 1995 Long term effects of antihypertensive agents on proteinuria and renal function. Arch Intern Med 155: 1073-1080
5. Michielson P, Lambert PP 1967 Effets du traitment par les corticosteroides et 1-indomethacine sur la proteinurie. Bull Mem Soc Med Hop Paris 118: 217-232
6. Niaudet P, Habib R 1994 Cyclosporine in the treatment of idiopathic nephrosis. J Am Soc Nephrol 5: 1049-1056
7. Ponticelli C, Passerini P 1994 Treatment of the nephrotic syndrome associated with primary glomerulonephritis. Kidney Int 46: 595-604
8. Remuzzi A, Remuzzi G 1995 The effects of nonsteroidal anti-inflammatory drugs on glomerular filtration of proteins and their therapeutic utility. Semin Nephrol 15: 236-243
9. Tiggeler RG, Hulme B, Wijdeveld PGAB 1979 Effect of indomethacin on glomerular permeability in the nephrotic syndrome. Kidney Int 16: 312-321
10. Valeri A, Padharkrishnan J, Estes D, D'Agati V, Kopelman V, Pernis A, Flis R, Pirani C, Appel GB 1994 Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study. Clin Nephrol 42: 71-78
11. Velosa JA, Torres VE 1986 Benifits and risks of nonsteroidal anti-inflammatory drugs in steroid-resistant nephrotic syndrome. Am J Kidney Dis 7: 345-350
12. Velosa JA, Torres VE, Donadio JV, Wagoner RD 1985 Treatment of severe nephrotic syndrome with meclofenamate: An uncontrolled pilot study. Mayo Clin Proc 60: 586-592
13. Vriesendorp R, Zeeuw DD, Jong PED, Danker AJM, Pratt JJ, van der Hem GK 1986 Reduction of urinary protein and prostanglandin E2 excretion in the nephrotic syndrome by non-steroidal anti-inflammatory drugs. Clin Nephrol 25: 105-110